Investor Relations

Investor Search

Entire IR Site
Press Releases Only
Filings Only
Email pagePDF viewPrint viewEmail AlertRSS FeedsTearsheetMobile IR SiteSocial Media Sharing

Press Releases


Display:

Year:
Notify me when new press releases are posted to this site .
Press Releases 
DateHeadlineFormat
3/26/2014Repligen Launches OPUS(R) Ready-to-Use Chromatography Columns With Largest Capacity Available on the Market
3/06/2014Repligen Reports Full Year and Fourth Quarter 2013 Financial Results
2/25/2014Repligen to Report Fourth Quarter and Fiscal Year 2013 Financial Results
1/21/2014Repligen Announces Asset Purchase Agreement With BioMarin for HDACi Portfolio
11/26/2013Repligen to Present at the 25th Annual Piper Jaffray Healthcare Conference
11/19/2013Repligen Appoints Biogen Idec Executive John G. Cox to Board of Directors
11/07/2013Repligen Reports Third Quarter 2013 Financial Results
11/06/2013Repligen to Present at the 2013 Stephens Fall Investment Conference
11/01/2013Repligen Completes Expansion of U.S. Manufacturing Facility
10/24/2013Repligen to Report Third Quarter 2013 Financial Results
9/04/2013Repligen to Present at the Stifel Healthcare Conference 2013
9/04/2013Repligen Receives First Milestone Payment From Pfizer Under Licensing Agreement for Spinal Muscular Atrophy Program
8/01/2013Repligen Reports Second Quarter 2013 Financial Results
7/18/2013Repligen to Report Second Quarter 2013 Financial Results
5/23/2013Repligen CEO to Present at Jefferies 2013 Global Healthcare Conference
5/02/2013Repligen Reports First Quarter 2013 Financial Results
4/23/2013Repligen to Report First Quarter 2013 Financial Results
3/07/2013Repligen Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Financial Guidance for 2013
3/01/2013Repligen to Report Fourth Quarter and Full Year 2012 Financial Results
1/03/2013Repligen Announces Licensing Agreement with Pfizer for Spinal Muscular Atrophy Program
 
 Source: SNL Financial LC
Rows 1 through 20 of 137 1 2 3 4 5 6 7

Copyright 2014, © SNL Financial LC  Terms of Use